Back

Electrical progression despite tafamidis in transthyretin cardiac amyloidosis

11 May 2026 (08:30 - 09:30)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome (5) Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rita Ventura

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

8 More presentations in this session

Presentation thumbnail
How ultra-rare is danon disease? an estimate of prevalence based on multiple data sources
Doctor M. Boslough (Aurora, US)
Abstract Slides
Presentation thumbnail
Admission congestion phenotypes and 6-month outcomes after heart failure hospitalisation
Doctor I. Moseley (New York, US)
Abstract Slides
Presentation thumbnail
Temporal distribution of 6-month adverse events following hospital discharge for heart failure
Doctor I. Moseley (New York, US)
Abstract Slides
Presentation thumbnail
Guideline-recommended medical therapy and outcomes in octogenarian patients with HFrEF
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Bridging gaps in heart failure care: how remote monitoring enhances health equity and access
Doctor S. Husheer (Cambridge, GB)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome (5)

The Event

Event poster

Heart Failure 2026

11 May 2026 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources